Substituted imidazoquinoline derivatives as kinase inhibitors
US9062046B2 · kind B2 · utility
9Cited by
1References
14Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jul 15, 2011 |
| Grant date | Jun 23, 2015 |
| Priority date | — |
| Expiry date | Jul 15, 2031 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY02A50/30
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to substituted imidazo[4,5-c]quinoline derivatives, the compounds of formula (I), wherein R1, R2, R3, R4, R5, R6 and R7 are as defined in the specification, processes for their preparation, pharmaceutical compositions comprising compounds of formula (I), and their use in the treatment of diseases or disorders mediated by one or more kinases, particularly proliferative diseases or disorders such as cancer. These compounds can also be used in the treatment of inflammatory diseases and angiogenesis related disorders.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.